Headquartered in Chattanooga, TN, CBL Properties owns and manages a national portfolio of market-dominant properties located in dynamic and growing communities. CBL's owned and managed portfolio is comprised of 94 properties totaling 58.5 million square feet across 22 states, including 56 high-quality enclosed malls, outlet centers and lifestyle retail centers as well as more than 30 open-air centers and other assets. CBL seeks to continuously strengthen its company and portfolio through active management, aggressive leasing and profitable reinvestment in its properties.

CBL & Associates Properties Inc.

An update from CBL & Associates Properties ( ($CBL) ) is now available. At its annual meeting of shareholders held on May 21, 2026, CBL & Associate...

CBL & Associates Shareholders Back Board and Governance Measures

In a report released on May 15, Travis Steed from Bank of America Securities maintained a Buy rating on Ceribell, Inc.. The company’s shares closed...

Bank of America Securities Remains a Buy on Ceribell, Inc. (CBLL)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ceribell, Inc. (CBLL) and AbCellera Biologics (ABCL)...

Analysts Offer Insights on Healthcare Companies: Ceribell, Inc. (CBLL) and AbCellera Biologics (ABCL)

Ceribell, Inc. (($CBLL)) has held its Q1 earnings call. Read on for the main highlights of the call. Ceribell’s latest earnings call struck a const...

Ceribell’s Earnings Call Signals Growth Over Profits

An update from China BlueChemical ( ($HK:3983) ) is now available. China BlueChemical has announced the resignation of executive director Ms. He Qu...

China BlueChemical Executive Director Resigns Amid Board Transition

China BlueChemical ( ($HK:3983) ) has provided an update. China BlueChemical has announced the current composition of its Board of Directors, detai...

China BlueChemical Clarifies Board and Committee Structure

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ceribell, Inc. (CBLL) and Climb Bio (CLYM) with bull...

Analysts Offer Insights on Healthcare Companies: Ceribell, Inc. (CBLL) and Climb Bio (CLYM)

ICICI Securities analyst Chirag Shah maintained a Hold rating on PCBL Chemical Limited today and set a price target of INR310.00. According to TipR...

PCBL Chemical Limited (PCBL) Receives a Hold from ICICI Securities

In a report released on April 29, Thomas Renaud from Kepler Capital maintained a Buy rating on MERSEN, with a price target of €36.00. The company’s...

MERSEN (0Q6Q) Receives a Buy from Kepler Capital

An announcement from China BlueChemical ( ($HK:3983) ) is now available. China BlueChemical issued a voluntary clarification after market rumours s...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CBL	$47.19	-0.08%	315.30K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CBL	$47.19	-0.1%	315.30K
3
4
5
6

CBL

CBL

No Data Available

Get CBL & Associates Properties Inc. Data in Excel

Get CBL & Associates Properties Inc. Data in Excel